FOXNEWS America Reports With John Roberts Sandra Smith October 15, 2021 17:34:00
Lot less certain than the case for both moderna and pfizer, why? >> the moderna case was there was a 13.6% increase in mild infection so it wasn't nearly as robust a concern as we saw with the pfizer vaccine with the data coming out of israel where it was increasing the risk of severe infections and hospitalizations after six months so moderna milder and they recommended approval. the first point is when you recommend approval, the fda is going to go along with it. not going to be a question about that, it will be approved for boosters over 65, that's the tradition of the fda. in terms of j&j,...
Source: archive.org